• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 Set7 依赖性甲基化 Yap 来控制 hippo 通路。

Control of the hippo pathway by Set7-dependent methylation of Yap.

机构信息

The Biomedical Research Centre, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

出版信息

Dev Cell. 2013 Jul 29;26(2):188-94. doi: 10.1016/j.devcel.2013.05.025. Epub 2013 Jul 11.

DOI:10.1016/j.devcel.2013.05.025
PMID:23850191
Abstract

Methylation of nonhistone proteins is emerging as a regulatory mechanism to control protein function. Set7 (Setd7) is a SET-domain-containing lysine methyltransferase that methylates and alters function of a variety of proteins in vitro, but the in vivo relevance has not been established. We found that Set7 is a modifier of the Hippo pathway. Mice that lack Set7 have a larger progenitor compartment in the intestine, coinciding with increased expression of Yes-associated protein (Yap) target genes. Mechanistically, monomethylation of lysine 494 of Yap is critical for cytoplasmic retention. These results identify a methylation-dependent checkpoint in the Hippo pathway.

摘要

组蛋白以外蛋白质的甲基化正逐渐成为一种调控蛋白质功能的机制。Set7(Setd7)是一种含有 SET 结构域的赖氨酸甲基转移酶,它可以体外甲基化并改变多种蛋白质的功能,但尚未确定其在体内的相关性。我们发现 Set7 是 Hippo 途径的调节因子。缺乏 Set7 的小鼠肠道中的前体细胞区室更大,与 Yes 相关蛋白(Yap)靶基因的表达增加相一致。从机制上讲,Yap 的赖氨酸 494 单甲基化对于细胞质保留至关重要。这些结果确定了 Hippo 途径中的一个依赖于甲基化的检查点。

相似文献

1
Control of the hippo pathway by Set7-dependent methylation of Yap.通过 Set7 依赖性甲基化 Yap 来控制 hippo 通路。
Dev Cell. 2013 Jul 29;26(2):188-94. doi: 10.1016/j.devcel.2013.05.025. Epub 2013 Jul 11.
2
SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/β-Catenin and Hippo/YAP Signaling.SETD7 通过调控 Wnt/β-连环蛋白和 Hippo/YAP 信号通路控制肠道再生和肿瘤发生。
Dev Cell. 2016 Apr 4;37(1):47-57. doi: 10.1016/j.devcel.2016.03.002.
3
Intestinal Epithelial Cell-Intrinsic Deletion of Setd7 Identifies Role for Developmental Pathways in Immunity to Helminth Infection.Setd7在肠道上皮细胞中的固有缺失揭示了发育途径在抗蠕虫感染免疫中的作用。
PLoS Pathog. 2016 Sep 6;12(9):e1005876. doi: 10.1371/journal.ppat.1005876. eCollection 2016 Sep.
4
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells.(R)-PFI-2是细胞中SETD7甲基转移酶活性的有效且选择性抑制剂。
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12853-8. doi: 10.1073/pnas.1407358111. Epub 2014 Aug 18.
5
SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.SET1A 介导的 YAP 第 342 位赖氨酸单甲基化通过阻断其核输出促进肿瘤发生。
Cancer Cell. 2018 Jul 9;34(1):103-118.e9. doi: 10.1016/j.ccell.2018.06.002. Epub 2018 Jun 28.
6
cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.cAMP/PKA 信号通路加强了 LATS-YAP 通路,以响应细胞骨架变化来完全抑制 YAP。
EMBO J. 2013 May 29;32(11):1543-55. doi: 10.1038/emboj.2013.102. Epub 2013 May 3.
7
An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.Hippo信号通路中一种进化上保守的负反馈机制反映了LATS1和LATS2之间的功能差异。
Oncotarget. 2016 Apr 26;7(17):24063-75. doi: 10.18632/oncotarget.8211.
8
Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.YAP内源性激活突变揭示的Hippo信号活性的稳态控制
Genes Dev. 2015 Jun 15;29(12):1285-97. doi: 10.1101/gad.264234.115.
9
Two faces of Hippo: activate or suppress the Hippo pathway in cancer.河马的两面性:在癌症中激活或抑制河马信号通路
Anticancer Drugs. 2017 Nov;28(10):1079-1085. doi: 10.1097/CAD.0000000000000559.
10
Neddylation mediates ventricular chamber maturation through repression of Hippo signaling.泛素化修饰通过抑制 Hippo 信号通路介导心室腔成熟。
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4101-E4110. doi: 10.1073/pnas.1719309115. Epub 2018 Apr 9.

引用本文的文献

1
Posttranslational modifications of YAP/TAZ: molecular mechanisms and therapeutic opportunities.YAP/TAZ的翻译后修饰:分子机制与治疗机遇
Cell Mol Biol Lett. 2025 Jul 17;30(1):83. doi: 10.1186/s11658-025-00760-4.
2
LDHA-mediated YAP lactylation promotes the tumor progression of hepatocellular carcinoma by inducing YAP dephosphorylation and activation.乳酸脱氢酶A(LDHA)介导的YAP乳酸化通过诱导YAP去磷酸化和激活来促进肝细胞癌的肿瘤进展。
Biol Direct. 2025 May 26;20(1):64. doi: 10.1186/s13062-025-00655-6.
3
Epigenetic histone modifications in kidney disease and epigenetic memory.
肾脏疾病中的表观遗传组蛋白修饰与表观遗传记忆
Clin Exp Nephrol. 2025 Apr 5. doi: 10.1007/s10157-025-02668-x.
4
Retarding human adipose-derived MSCs senescence and promoting tendon repair using cell sheet engineering with a histone methyltransferase inhibitor.使用组蛋白甲基转移酶抑制剂通过细胞片工程延缓人脂肪来源间充质干细胞衰老并促进肌腱修复。
Sci Rep. 2025 Feb 20;15(1):6198. doi: 10.1038/s41598-025-89234-3.
5
TAZ interactome analysis using nanotrap-based affinity purification-mass spectrometry.使用基于纳米阱的亲和纯化-质谱法进行TAZ相互作用组分析。
J Cell Sci. 2025 Feb 15;138(4). doi: 10.1242/jcs.263527. Epub 2025 Feb 24.
6
Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance.YAP的精氨酸甲基化与甲硫氨酸转运蛋白SLC43A2之间的正反馈驱动抗癌药物耐药性。
Nat Commun. 2025 Jan 2;16(1):87. doi: 10.1038/s41467-024-55769-8.
7
PRMT1-mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation.PRMT1介导的精氨酸甲基化促进YAP激活和肝细胞癌增殖。
FEBS Open Bio. 2024 Dec;14(12):2104-2112. doi: 10.1002/2211-5463.13909. Epub 2024 Oct 4.
8
Ribosome specialization in cancer: a spotlight on ribosomal proteins.癌症中的核糖体特化:聚焦核糖体蛋白
NAR Cancer. 2024 Jul 9;6(3):zcae029. doi: 10.1093/narcan/zcae029. eCollection 2024 Sep.
9
The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation.RNF214-TEAD-YAP 信号轴通过 TEAD 泛素化促进肝细胞癌进展。
Nat Commun. 2024 Jun 11;15(1):4995. doi: 10.1038/s41467-024-49045-y.
10
Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development.赖氨酸特异性甲基转移酶 Set7/9 在干性、分化和发育中的作用。
Biol Direct. 2024 May 29;19(1):41. doi: 10.1186/s13062-024-00484-z.